Incontinence, Nighttime Urinary

3

Review clinical trials related to Incontinence, Nighttime Urinary. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)

UCon is a medical device for treatment of the symptoms of overactive bladder (OAB) and bowel dysfunction (BD). It electrically stimulates the DGN through the skin to obtain modulated behaviour of the bladder/bowel musculature e.g., suppress undesired bladder/bowel activity to relieve the symptoms of the patient. This clinical investigation is designed as a single-arm, prospective, multi-centre, and early feasibility study.

Participants needed: 20
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: InnoCon MedicalUpdated: Feb 18, 2026Locations: 3
Eligibility criteria

Participant is female [+3]

Participant is medically unstable (acute illness or complication of a chronic co... [+9]

Status: Recruiting

UCon Treatment of Overactive Bladder (OAB) in Males

UCon is a medical device for treatment of the symptoms of OAB and fecal incontinence (FI). It electrically stimulates the DGN through the skin to obtain modulated behaviour of the bladder musculature e.g., suppress undesired bladder activity to relieve the symptoms of the patient. This clinical investigation is a randomized, cross-over, single-site, prospective, early feasibility study, which is used to evaluate Ucon with respect to its initial clinical safety and device performance in a small number of males with OAB.

Participants needed: 20
Trial details
Age: 18+Biological sex: MaleType: InterventionalSponsor: InnoCon MedicalUpdated: Oct 1, 2025Locations: 1
Eligibility criteria

Subject is ≥ 18 years of age. [+3]

Subject is medically unstable (acute illness or complications of a chronic condi... [+11]

Status: Recruiting

Safety and Performance of UCon Patch Electrode

UCon is a medical device for treating the symptoms of overactive bladder (OAB) and bowel dysfunction (BD). It electrically stimulates the DGN through the skin to obtain modulated behavior of the bladder/bowel musculature e.g., suppressing undesired bladder/bowel activity to relieve the symptoms of the patient. This pivotal clinical investigation is designed as a stratified-randomized, single-blinded, controlled, confirmatory, prospective, multicenter clinical investigation.

Participants needed: 180
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: InnoCon MedicalUpdated: Mar 27, 2025Locations: 3
Eligibility criteria

Participant is ≥ 18 years of age. [+2]

Participant has genital anatomy that does not allow for proper electrode placeme... [+30]